Published in Eur J Heart Fail on January 01, 2010
Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy. Eur Radiol (2014) 0.79
Diagnostic performance of cardiac magnetic resonance for the detection of acute cardiac allograft rejection: a systematic review and meta-analysis. J Thorac Dis (2015) 0.77
Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 2: emerging applications. Tex Heart Inst J (2014) 0.75
Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study. Int J Cardiovasc Imaging (2013) 0.75
Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation. Clin Res Cardiol (2014) 0.75
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant (2006) 3.78
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant (1993) 1.92
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant (1990) 1.91
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant (2003) 1.54
Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart (1999) 1.43
Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol (2001) 1.27
Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation (1995) 1.16
Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant (1996) 1.12
Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant (1996) 1.07
Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation (2004) 1.06
The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. J Heart Lung Transplant (1996) 1.01
Changes in health-related quality of life and depression in heart transplant recipients. J Heart Lung Transplant (1995) 0.88
Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc (2003) 0.85
Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology (1992) 0.85
Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol (2002) 0.85
Pathological findings in 2300 consecutive endomyocardial biopsies. Mod Pathol (1991) 0.80
The signal-averaged electrocardiogram in cardiac transplantation. A noninvasive marker of acute allograft rejection. Transplantation (1992) 0.79
Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol (2008) 5.71
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension (2003) 3.29
Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med (2003) 2.96
Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr (2013) 2.83
Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol (2009) 2.68
Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol (2011) 2.57
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry (2008) 2.43
Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol (2010) 2.37
NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods (2011) 2.29
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens (2007) 2.09
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest (2003) 1.98
Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust (2010) 1.91
Cardiac complications of thoracic irradiation. J Am Coll Cardiol (2013) 1.80
Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension (2006) 1.77
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail (2012) 1.76
Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol (2011) 1.72
Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol (2012) 1.70
Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Thorac Surg (2010) 1.67
Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure. Eur J Heart Fail (2011) 1.60
Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy. Circ Heart Fail (2014) 1.58
Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant (2009) 1.58
Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest (2008) 1.46
Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens (2005) 1.44
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm (2013) 1.44
Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure. Eur Heart J (2005) 1.43
Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem (2007) 1.42
Retinal detachment. Lancet (2003) 1.39
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation (2003) 1.38
Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ Res (2014) 1.29
Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation (2011) 1.26
Hospital characteristics are associated with patient outcomes following out-of-hospital cardiac arrest. Heart (2011) 1.25
Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation (2004) 1.23
Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant (2005) 1.20
Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson (2012) 1.18
Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology (2008) 1.15
Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol (2011) 1.15
Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth. J Med Chem (2003) 1.14
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol (2010) 1.11
Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics (2011) 1.10
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation (2004) 1.10
Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res (2007) 1.08
Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation. Pacing Clin Electrophysiol (2006) 1.05
Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation (2007) 1.05
Opportunistic childhood vaccinations in emergency--are we really missing anyone? Australas Emerg Nurs J (2012) 1.05
Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover. J Physiol (2011) 1.03
Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am J Clin Nutr (2007) 1.03
Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation (2003) 1.02
Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol (2008) 1.02
Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol (2010) 1.01
Effectiveness of a multi-strategy intervention in increasing the implementation of vegetable and fruit breaks by Australian primary schools: a non-randomized controlled trial. BMC Public Health (2012) 1.01
Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension. Hum Mutat (2009) 1.00
The silent treatment: parents' narratives of sexuality education with young people. Cult Health Sex (2010) 0.99
Complementary alternative medicine (CAM) use in Ireland: a secondary analysis of SLAN data. Complement Ther Med (2010) 0.99
Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest (2003) 0.99
Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience. J Heart Lung Transplant (2007) 0.97
CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circ Heart Fail (2011) 0.97
Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension (2010) 0.96
Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation (2004) 0.95
Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv (2012) 0.94
Exercise training increases arterial compliance in patients with congestive heart failure. Clin Sci (Lond) (2002) 0.94
Responses to pandemic (H1N1) 2009, Australia. Emerg Infect Dis (2010) 0.92
Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol (2011) 0.91
Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res (2006) 0.91
B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med (2009) 0.91
Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation (2008) 0.89
Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation (2002) 0.89
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer (2010) 0.89
Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+ dependence, and structure-activity relationship. J Biol Chem (2003) 0.89
Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation. Am J Physiol Heart Circ Physiol (2005) 0.88
Vegetable and fruit breaks in Australian primary schools: prevalence, attitudes, barriers and implementation strategies. Health Educ Res (2011) 0.87
Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization. Anal Biochem (2004) 0.87
A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). Am Heart J (2012) 0.87
Determination of plasma free 3-nitrotyrosine and tyrosine by reversed-phase liquid chromatography with 4-fluoro-7-nitrobenzofurazan derivatization. Biomed Chromatogr (2007) 0.86
Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure. Catheter Cardiovasc Interv (2006) 0.86
Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected]. J Heart Lung Transplant (2009) 0.86
Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhythm Electrophysiol (2013) 0.86
Accuracy of Doppler echocardiography to estimate key hemodynamic variables in subjects with normal left ventricular ejection fraction. J Card Fail (2011) 0.86
Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Card Fail (2012) 0.85
An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail (2002) 0.85
Prolonged cardiac allograft ischemic time--no impact on long-term survival but at what cost? Clin Transplant (2007) 0.85
Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a longitudinal study. Transpl Immunol (2007) 0.85
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure. Eur Heart J (2003) 0.85
An evaluation of the appropriateness and safety of nurse and midwife prescribing in Ireland. J Adv Nurs (2012) 0.85